Clinical Study
Long-Term Efficacy of Postpartum Intravenous Iron Therapy
Table 1
Baseline data and characteristics.
| Characteristics | Oral iron | Intravenous + oral iron | | ( = 150) | ( = 75) |
| Maternal age at delivery (years) | 32.1 (5.4) | 31.5 (6.1) | 0.46 | Gestational age (weeks) | 39.2 (2.9) | 39.1 (3.0) | 0.91 | Gravidity | 2.0 (1.4) | 2.1 (1.6) | 0.77 | Parity | 1.6 (0.9) | 1.5 (1.1) | 0.63 | Blood loss, estimated (mL) | 537.2 (283.5) | 625.9 (404.9) | 0.06 | Hb after delivery (g/dL) | 10.1 (0.3)9.5–10.5 | 9.1 (0.3)8.5–9.5 | <0.0001 | Haematocrit after delivery (%) | 29.5 (1.4)25.4–36.2 | 26.9 (1.7)23–31.5 | <0.0001 | Mode of delivery | | | | Vaginal spontaneous | 54 (36%) | 33 (44%) | | Vaginal operative | 28 (18.7%) | 9 (12%) | | Caesarean section | 68 (45.3%) | 33 (44%) | |
|
|
Values are expressed as mean (SD) range, or numbers and percentages.
|